Lupin said, "It has launched its Norgestimate and Ethinyl Estradiol tablets USP, 0.25 mg/0.035 mg having received approval from US FDA earl...

The transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...

The deal allow us to leverage our distribution and our marketing network in over 50 countries, said Nandini Piramal.

Piramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.

Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estrad...

Approval has been granted for generic version of Ortho Tri-cyclen Lo tablets of Janssen Pharmaceuticals, Inc.

Dishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...

Dishman Pharmaceuticals and Chemicals surged 16.22 per cent to close at 306.95. The stock closed at a fresh 52-week high on Wednesday.

Taken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...

Jubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...

Lupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.

Glenmark Pharmaceuticals today said it has settled litigation with Janssen Pharmaceuticals Inc over patent actions regarding generic oral c...

After gaining market access under a USFDA contingency plan, Sun Pharma is awaiting approval for its cancer drug Lipodox.

Danish pharma firm Genmab has said that it had reached a deal worth up to $1.1 bn with US drug giant Johnson & Johnson.

Sun Pharmaceutical Industries Ltd said it has received an approval from the FDA to sell generic drug galantamine hydrobromide used in treat...

Sun Pharma said US health regulator Food and Drug Administration has approved its Abbreviated New Drug Application (ANDA) to market generic...

Janssen-Cilag and its parent Johnson and Johnson Pharmaceutical Research and Development (J&JPRD) on Tuesday opened an analytical and pharm...